RR
Raju Ranganathan
About Raju Ranganathan
Data last updated:
Raju Ranganathan is a Director at Hibiscus Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Hibiscus Pharmaceuticals Private Limited reported revenue of ₹10.93 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Aug 2022 | 2007 | ₹10.93 Cr (FY 2025) | Active |
Board colleagues of Raju Ranganathan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alamelu Sathya Priya | 02042053 | Hibiscus Pharmaceuticals Private Limited | Director |
| Balabanumathi Venkatesh | 01570753 | Hibiscus Pharmaceuticals Private Limited | Director |
| Sathiyamurthi Vanisaraswathi | 01976227 | Hibiscus Pharmaceuticals Private Limited | Director |
| Sivasundaran Venkatesh | 07268978 | Hibiscus Pharmaceuticals Private Limited | Managing Director |
| Srinivasan Ashalatha | 01153676 | Hibiscus Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raju Ranganathan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raju Ranganathan
Raju Ranganathan currently holds 1 directorship: Hibiscus Pharmaceuticals Private Limited (Director, since 25 Aug 2022, revenue ₹10.93 Cr (FY 2025)).
Raju Ranganathan was first appointed on 25 Aug 2022 as Director at Hibiscus Pharmaceuticals Private Limited.
The current boards of Raju Ranganathan's companies include Alamelu Sathya Priya (Hibiscus Pharmaceuticals Private Limited), Balabanumathi Venkatesh (Hibiscus Pharmaceuticals Private Limited), Sathiyamurthi Vanisaraswathi (Hibiscus Pharmaceuticals Private Limited), Sivasundaran Venkatesh (Hibiscus Pharmaceuticals Private Limited), Srinivasan Ashalatha (Hibiscus Pharmaceuticals Private Limited).